Cosciens Biopharma Inc (CSCI)

$3.56

+0.02

(+0.57%)

Market is closed - opens 7 PM, 04 Nov 2024

Performance

  • $3.52
    $3.74
    $3.56
    downward going graph

    1.12%

    Downside

    Day's Volatility :5.88%

    Upside

    4.81%

    downward going graph
  • $3.49
    $6.77
    $3.56
    downward going graph

    1.97%

    Downside

    52 Weeks Volatility :48.48%

    Upside

    47.44%

    downward going graph

Returns

PeriodCosciens Biopharma IncIndex (Russel 2000)
3 Months
-42.35%
0.0%
6 Months
-42.35%
0.0%
1 Year
-42.35%
0.0%
3 Years
-42.35%
-25.0%

Highlights

Market Capitalization
13.1M
Book Value
$8.57
Earnings Per Share (EPS)
-2.69
Profit Margin
0.0%
Operating Margin TTM
-160.68%
Return On Assets TTM
-23.34%
Return On Equity TTM
-65.92%
Revenue TTM
4.9M
Revenue Per Share TTM
3.76
Quarterly Revenue Growth YOY
4.1000000000000005%
Gross Profit TTM
0.0
EBITDA
-18.0M
Diluted Eps TTM
-2.69
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Technicals Summary

Sell

Neutral

Buy

Cosciens Biopharma Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cosciens Biopharma Inc
Cosciens Biopharma Inc
-6.84%
-42.35%
-42.35%
-42.35%
-42.35%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-19.94%
-7.23%
5.93%
31.14%
169.97%
Biontech Se
Biontech Se
-5.69%
25.74%
21.03%
-58.77%
584.62%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
-3.43%
77.77%
69.8%
60.25%
192.92%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
1.32%
18.36%
28.88%
156.73%
136.88%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cosciens Biopharma Inc
Cosciens Biopharma Inc
NA
NA
NA
0.0
-0.66
-0.23
NA
8.57
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
24.57
24.57
1.27
44.77
0.17
0.08
NA
261.41
Biontech Se
Biontech Se
160.8
NA
0.04
-2.76
-0.03
-0.02
NA
80.22
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-2.39
-15.01
0.02
NA
-0.02
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
0.57
0.16
-0.03
0.13
NA
57.26
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cosciens Biopharma Inc
Cosciens Biopharma Inc
NA
$13.1M
-42.35%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$102.2B
169.97%
24.57
32.04%
Biontech Se
Biontech Se
Buy
$27.1B
584.62%
160.8
-18.75%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$36.5B
192.92%
NA
-3.11%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$122.6B
136.88%
32.84
-4.74%

Company Information

æterna zentaris inc. (tsx: aez, nasdaq: aezs) is a global biopharmaceutical company focused on endrocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization. æterna zentaris inc. (tsx: aez, nasdaq: aezs) est une société biopharmaceutique internationale, spécialisée dans la découverte, le développement et la commercialisation de thérapies en endocrinologie et en oncologie.

Organization
Cosciens Biopharma Inc
Employees
0
CEO
Mr. Gilles R. Gagnon ICD.D, M.B.A., M.Sc.
Industry
Miscellaneous

FAQs